Survival advantage associated with metformin usage in hepatocellular carcinoma patients with diabetes mellitus receiving radical resection: a propensity score matching analysis

Metformin is associated with improved survival among hepatocellular carcinoma (HCC) patients with diabetes mellitus. However, the role of metformin in the survival of hepatitis B virus (HBV)-related HCC patients with diabetes mellitus after radical resection is unclear, so this study aimed to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Cui-Song, Lin, Yun, Zhou, Wei-Ping, Shi, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2019
Materias:
Original Articles: Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337117/
https://www.ncbi.nlm.nih.gov/pubmed/31764404
http://dx.doi.org/10.1097/MEG.0000000000001610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337117/
https://www.ncbi.nlm.nih.gov/pubmed/31764404
http://dx.doi.org/10.1097/MEG.0000000000001610

Ejemplares similares